Background/purpose: NK cells are important antiviral effectors of innate immunity because of their contribution to virus elimination in chronic hepatitis B virus (HBV) infection.
Background: The efficacy of continuous entecavir (ETV) therapy in patients with detectable HBV DNA at 48 weeks is still controversial Aim: To compare the long term continuous efficacy of ETV in chroni
OBJECTIVE: To develop a sensitive and accurate assay system for the quantification of covalently closed circular HBV DNA (cccDNA) for future clinic monitoring of cccDNA fluctuation during antiviral th
Background and Aim: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.Most hepatocellular carcinomas develop in the background of the advanced liver fibrosis and cirrhosi